Journalism awards received by The Cancer Letter

  • 2016 Dateline Award, Society of Professional Journalists, Washington, D.C. Chapter. Series, Newsletter/Trade Publications, first place, for “How Medical Devices Do Harm,” a series on reporting of adverse outcomes, patient safety laws, and FDA regulation of medical devices.
  • 2016 Best in Business Award for Outstanding Business Journalism, Society of American Business Editors and Writers. Print Weeklies/Biweeklies in Investigative Journalism, second place/finalist, for “How Medical Devices Do Harm,” a series on reporting of adverse outcomes, patient safety laws, and FDA regulation of medical devices.
  • 2016 Azbee Award of Excellence, American Society of Business Publication Editors. Feature Series, Mid Atlantic, second place, for “How Medical Devices Do Harm,” a series on reporting of adverse outcomes, patient safety laws, and FDA regulation of medical devices.
  • 2016 Health Care Journalism Award, National Institute for Health Care Management Foundation. Print Journalism Award, Trade Publications, finalist, for “How Medical Devices Do Harm,” a series on reporting of adverse outcomes, patient safety laws, and FDA regulation of medical devices.
  • 2015 National Press Club Award for Excellence in Journalism. Best Analytical/Interpretive Reporting in Newsletter Journalism, first place, for “Power Morcellation: A Hazardous Practice,” a series on power morcellators and FDA medical device regulation.
  • 2015 Sigma Delta Chi Award for Excellence in Journalism, Society of Professional Journalists. Public Service in Newsletter Journalism, winner, for “Power Morcellation: A Hazardous Practice,” a series on power morcellators and FDA medical device regulation.
  • 2015 Dateline Award, Society of Professional Journalists, Washington, D.C. Chapter. Newsletter Washington Reporting, first place, for “Power Morcellation: A Hazardous Practice,” a series on power morcellators and FDA medical device regulation.
  • 2015 Iris Molotsky Award for Excellence in Coverage of Higher Education, American Association of University Professors. Finalist, for “No Justification Provided,” a series on violations of academic freedom, tenure, and shared governance standards at MD Anderson Cancer Center.
  • 2014 Dateline Award, Society of Professional Journalists, Washington, D.C. Chapter. Newsletter Washington Reporting, first place, for series on conflicts of interest at MD Anderson Cancer Center.
  • 2011 Dateline Award, Society of Professional Journalists, Washington, D.C. Chapter. Newsletter Washington Reporting, second place, for “The Duke Genomics Scandal.”
  • 2010 Award for Excellence in Health Care Journalism, Association of Health Care Journalists. Trade publications, third place, for “The Duke Debacle: Misadventures in Personalized Medicine.”
  • 2008 Award for Excellence in Health Care Journalism, Association of Health Care Journalists. Trade publications, first place, for series on conflicts of interest in lung cancer cancer study (I-ELCAP).
  • 2008 Dateline Award, Society of Professional Journalists, Washington D.C. Chapter. Newsletter Washington Reporting, second place, for series of stories on erythropoiesis stimulating agents in the treatment of cancer.
  • 2007 Dateline Award, Society of Professional Journalists, Washington D.C. Chapter. Newletter Washington Reporting, second place, for “I-ELCAP ‘Soundbites’ For Investigators Were A Protocol For Spin, Critics Say,” (The Cancer Letter, Nov. 22, 2006).
  • 2006 Dateline Award, Society of Professional Journalists, Washington D.C. Chapter. Newsletter Public Service, third place, for articles on the anti-efficacy agenda for drug approval and Andrew von Eschenbach’s unprecedented eight-month dual role as NCI director and acting FDA commissioner.
  • 2005 Dateline Award, Society of Professional Journalists, Washington D.C. Chapter. Newsletter Washington Reporting, first place, for a story about the dietary supplement PC-Spes.
  • 2004 Robert D.G. Lewis Watchdog Award, Society of  Professional Journalists, Washington D.C. Chapter, for series on the agenda of NCI Director Andrew von Eschenbach.
  • 2004 Dateline Award, Society of Professional Journalists, Washington D.C.  Chapter. Newsletter Washington Reporting, first place, for series on the agenda of NCI Director Andrew von Eschenbach.
  • 2003 Finalist, Gerald Loeb Awards for Distinguished Business and Financial Journalism presented by The Anderson School at UCLA, for series on ImClone Inc.
  • 2003 Robert D.G. Lewis Watchdog Award, Society of Professional Journalists, Washington D.C. Chapter, for series on ImClone.
  • 2003 Newsletter Journalism Award, Newsletter and Electronic Publishers Foundation. Best Investigative Reporting, third place, for series on ImClone Inc.
  • 2003 Dateline Award, Society of Professional Journalists, Washington D.C. Chapter. Newsletter Washington Reporting, first place, for series on ImClone Inc.
  • 2001 Newsletter Journalism Award, Newsletter and Electronic Publishers Foundation. Best Investigative Reporting, second place, for series on the National Dialogue on Cancer.
  • 2001 Dateline Award, Society of Professional Journalists Washington D.C Chapter. Newsletter Washington Reporting, honorable mention, for series on the National Dialogue on Cancer.
  • 1999 Robert D.G. Lewis Award, Society of Professional Journalists, Washington D.C. Chapter, for series on cancer treatment studies by Houston practitioner Stanislaw Burzynski.
  • 1999 Newsletter Journalism Award, Newsletter and Electronic Publishers Foundation. Best Investigative Reporting, third place, for series on Stanislaw Burzynski.
  • 1999 Dateline Award, Society of Professional Journalists, Washington D.C. Chapter. Newsletter Washington Reporting, first place, for series on Stanislaw Burzynski.
  • 1998 Dateline Award, Society of Professional Journalists, Washington D.C. Chapter. Newsletter Washington Reporting, honorable mention, for series on mammography screening.